Inventor · disambiguated record
Marion Jurk
Also filed as: JURK MARION · JÜRK MARION
12 granted patents·8 pending applications·208 citations·filing 2002–2017
91Inventor score
Files withCOLEY PHARM GMBH4COLEY PHARM GROUP INC4JURK MARION3KRIEG ARTHUR M2SAREPTA THERAPEUTICS INC2
Top patents by PatentIndex Score
20 records- 0195US7956043B25′ CpG nucleic acids and methods of useCOLEY PHARM GROUP INC·Filed 2003·Granted Jun 7, 2011·82 cites·15 claims
- 0294US8304396B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2006·Granted Nov 6, 2012·38 cites·9 claims
- 0391US8580268B2CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activityDEBELAK HARALD·Filed 2007·Granted Nov 12, 2013·31 cites·7 claims
- 0490US8283328B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2003·Granted Oct 9, 2012·40 cites·11 claims
- 0584US8128944B2RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profilesJURK MARION·Filed 2008·Granted Mar 6, 2012·7 cites·6 claims
- 0681US9200287B2Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activityUHLMANN EUGEN·Filed 2008·Granted Dec 1, 2015·5 cites·11 claims
- 0779US10260071B2CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activityCOLEY PHARM GMBH·Filed 2016·Granted Apr 16, 2019·2 cites·9 claims
- 0872US9382545B2CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activityCOLEY PHARM GMBH·Filed 2013·Granted Jul 5, 2016·1 cites·8 claims
- 0969US8466124B2RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profilesJURK MARION·Filed 2012·Granted Jun 18, 2013·1 cites·5 claims
- 1069US8227447B2RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profilesJURK MARION·Filed 2012·Granted Jul 24, 2012·1 cites·2 claims
- 1158US9186399B2Immune stimulatory oligonucleotide analogs containing modified sugar moietiesUHLMANN EUGEN·Filed 2008·Granted Nov 17, 2015·0 cites·17 claims
- 1254US2005239733A1Sequence requirements for inhibitory oligonucleotidesCOLEY PHARM GROUP INC·Filed 2004·Application pending·0 cites
- 1352US2015344884A1Inhibitory oligonucleotides and their use in therapySAREPTA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1450US2006188913A1Methods and products for enhancing immune responses using imidazoquinoline compoundsCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 1548US2010144846A1Oligoribonucleotides and uses thereofCOLEY PHARM GMBH·Filed 2007·Application pending·0 cites
- 1647US2003139364A1Methods and products for enhancing immune responses using imidazoquinoline compoundsUNIV IOWA RES FOUND·Filed 2002·Application pending·0 cites
- 1746US2010189772A1Compositions of TLR ligands and antiviralsCOLEY PHARM GROUP INC·Filed 2007·Application pending·0 cites
- 1845US12275950B2In vitro method of reprogramming fibroblast cells into induced pluripotent stem cells by transcription factors mRNAs co-transfected with SOCS1 mRNA wherein the mRNAs have a poly-A tail of at least 2000 adeninesMILTENYI BIOTEC GMBH·Filed 2017·Granted Apr 15, 2025·0 cites·5 claims
- 1945US2016355822A1Inhibitory oligonucleotides and their use in therapySAREPTA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2041US2009306177A1Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide ModificationCOLEY PHARM GMBH·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marion Jurk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →